// App-Quantinova.ai

POS0395 (2022) : EXPLORING THE POTENTIAL OF GENOMIC RISK PREDICTION FOR CORONARY ARTERY DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS

Researchers

Presenter

  • M. Soomro

Principal Investigators

  • M. Stadler

  • S. Viatte

  • J. Bowes

  • A. Barton

  • S. Verstappen

  • A. Macgregor

Medical Centers

  • The University of Manchester, Centre for Epidemiology Versus Arthritis, Faculty of Biology, Medicine and Health, Greater Manchester, United Kingdom

  • The University of Manchester, Centre for Epidemiology Versus Arthritis, Faculty of Biology, Medicine and Health, Greater Manchester, United Kingdom

  • University of East Anglia, Rheumatology Department, Norfolk and Norwich University Hospitals NHS Trust, Norwich, UK, Norwich, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Cardiovascular (CVS)

Disease

  • Rheumatoid arthritis

  • Coronary Artery Disease

  • Inflammatory Arthritis

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved